New technology, which hundred of thousands of women will be invited to help test over the coming months, could improve ...

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

NICE judged that ‘more data is needed to be certain that these technologies do not incorrectly detect or miss skin cancer in ...

Novartis UK announced the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised ribociclib for adjuvant ...

Katherine was first diagnosed with cancer at just 16 - now at 27 she is cancer-free and wants to 'give something back' to the ...

Nearly 700,000 women across the UK will take part in an NHS Artificial Intelligence (AI) trial designed to detect breast ...

Novartis’ Kisqali (ribociclib) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat a ...

Nearly 700,000 women across the country will take part in a world-leading trial to test how cutting-edge AI tools can be used to catch breast cancer cases earlier, the Department of Health and Social ...

In the UK, a major new study will investigate the use of artificial intelligence in speeding up breast cancer diagnosis. <br /><br /> ...

An incurable disease we are, sadly, all too familiar with in the country is cancer, especially breast cancer. Around 4,800 ...

The cancer centre, formerly known as St Luke’s, was originally opened by Her Majesty Queen Elizabeth II in 1997. Following ...